Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Lheureux

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2018
Biomarker Discovery from We to Me: Is Learning from Each Patient a New Approach?Stephanie Lheureux
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2022
Multi-omics Uncovering Different Faces of Clear Cell Ovarian CancerStephanie Lheureux
Frontiers in Cell and Developmental Biology|September 22, 2025
Interplay of replication stress response and immune microenvironment in high-grade serous ovarian cancerLaura Venegas, Stephanie Lheureux
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Overcoming PARP inhibitor resistance in ovarian cancerPamela Soberanis Pina, Stephanie Lheureux
The Lancet. Oncology|April 18, 2015
Targeting the microenvironment in ovarian cancerStephanie Lheureux, Amit M Oza
European Journal of Cancer (Oxford, England : 1990)|March 28, 2016
Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatmentsStephanie Lheureux, Amit M Oza
Biologics : Targets & Therapy|March 26, 2024
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for TherapyPamela Soberanis Pina, Stephanie Lheureux
Seminars in Cancer Biology|September 2, 2020
New approaches for targeting platinum-resistant ovarian cancerMichelle McMullen, Ainhoa Madariaga, Stephanie Lheureux
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2025
High-grade serous ovarian cancer-bridging the gap between epidemiology and prevention with biologySmadar Bauer, Amit Oza, Stephanie Lheureux
Expert Opinion on Emerging Drugs|March 13, 2018
Emerging growth factor receptor antagonists for ovarian cancer treatmentLuisa Bonilla, Amit Oza, Stephanie Lheureux
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2018
Biomarker Discovery from We to Me: Is Learning from Each Patient a New Approach?Stephanie Lheureux
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2022
Multi-omics Uncovering Different Faces of Clear Cell Ovarian CancerStephanie Lheureux
Frontiers in Cell and Developmental Biology|September 22, 2025
Interplay of replication stress response and immune microenvironment in high-grade serous ovarian cancerLaura Venegas, Stephanie Lheureux
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Overcoming PARP inhibitor resistance in ovarian cancerPamela Soberanis Pina, Stephanie Lheureux
The Lancet. Oncology|April 18, 2015
Targeting the microenvironment in ovarian cancerStephanie Lheureux, Amit M Oza
European Journal of Cancer (Oxford, England : 1990)|March 28, 2016
Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatmentsStephanie Lheureux, Amit M Oza
Biologics : Targets & Therapy|March 26, 2024
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for TherapyPamela Soberanis Pina, Stephanie Lheureux
Seminars in Cancer Biology|September 2, 2020
New approaches for targeting platinum-resistant ovarian cancerMichelle McMullen, Ainhoa Madariaga, Stephanie Lheureux
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2025
High-grade serous ovarian cancer-bridging the gap between epidemiology and prevention with biologySmadar Bauer, Amit Oza, Stephanie Lheureux
Expert Opinion on Emerging Drugs|March 13, 2018
Emerging growth factor receptor antagonists for ovarian cancer treatmentLuisa Bonilla, Amit Oza, Stephanie Lheureux
Pageof 15